Price
$1.71
Decreased by -2.29%
Dollar Volume (20D)
17.21 K
ADR%
5.7
Earnings Report Date (estimate)
Jun 26, 24
Shares Float
2.58 M
Shares Outstanding
2.62 M
Shares Short
9.9 K
Market Cap.
4.59 M
Beta
1.9
Price / Earnings
N/A
20D Range
1.61 1.85
50D Range
1.6 2.1
200D Range
1.4 5
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Feb 14, 24 -1.37
Decreased by -1.04 K%
-1.23
Decreased by -11.38%
Nov 14, 23 -1.22
Decreased by -577.78%
-1.4
Increased by +12.86%
Aug 10, 23 -0.14
Increased by +26.32%
-0.13
Decreased by -7.69%
Jun 28, 23 -0.1
Increased by +61.54%
-0.13
Increased by +23.08%
Feb 13, 23 -0.12
Increased by +25%
-0.08
Decreased by -50%
Nov 14, 22 -0.18
Decreased by -38.46%
-0.21
Increased by +14.29%
Aug 9, 22 -0.19
Decreased by -18.75%
-0.22
Increased by +13.64%
Jun 28, 22 -0.26
Decreased by -73.33%
-0.14
Decreased by -85.71%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 23 0
Decreased by N/A%
-3.47 B
Decreased by -124.96 K%
Decreased by N/A%
Decreased by N/A%
Sep 30, 23 0
Decreased by N/A%
-3.03 M
Increased by +23.17%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0
Decreased by N/A%
-3.28 M
Decreased by -12.96%
Decreased by N/A%
Decreased by N/A%
Mar 31, 23 574.25 K
Increased by +4.28 K%
-2.46 M
Increased by +35.11%
Decreased by -427.69%
Increased by +98.52%
Dec 31, 22 0
Decreased by -100%
-2.77 M
Decreased by -9.74%
Decreased by N/A%
Decreased by N/A%
Sep 30, 22 0
Decreased by -100%
-3.95 M
Decreased by -96.69%
Decreased by N/A%
Decreased by N/A%
Jun 30, 22 0
Decreased by -100%
-2.91 M
Decreased by -38.54%
Decreased by N/A%
Decreased by N/A%
Mar 31, 22 13.12 K
Decreased by -61.69%
-3.79 M
Decreased by -67.26%
Decreased by -28.86 K%
Decreased by -336.56%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.